Orange Book product · Generic (ANDA)
DOXERCALCIFEROL
DOXERCALCIFEROL
At a glance
Feb 07, 2020
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 07, 2020
6 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
DOXERCALCIFEROL
Strength
4MCG/2ML (2MCG/ML)
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 211670
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of DOXERCALCIFEROL
- 2018DOXERCALCIFEROLBrand (NDA)
NDA 208614 · HOSPIRA
- 2004HECTOROLBrand (NDA)
NDA 020862 · SANOFI
- 2000HECTOROLBrand (NDA)
NDA 021027 · SANOFI
- 2023DOXERCALCIFEROLGeneric (ANDA)
ANDA 215810 · ALEMBIC
- 2022DOXERCALCIFEROLGeneric (ANDA)
ANDA 213717 · EUGIA PHARMA
- 2020DOXERCALCIFEROLGeneric (ANDA)
ANDA 205360 · AVET
- 2019DOXERCALCIFEROLGeneric (ANDA)
ANDA 203875 · SUN PHARM
- 2019DOXERCALCIFEROLGeneric (ANDA)
ANDA 210452 · GLAND
- 2018DOXERCALCIFEROLGeneric (ANDA)
ANDA 210801 · LUPIN
- 2017DOXERCALCIFEROLGeneric (ANDA)
ANDA 208974 · AMNEAL
- 2017DOXERCALCIFEROLGeneric (ANDA)
ANDA 208975 · AMNEAL
- 2016DOXERCALCIFEROLGeneric (ANDA)
ANDA 201518 · RISING
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
